Aura Biosciences (AURA) Exchange Rate Effect (2025 - 2026)
Aura Biosciences' (AURA) quarterly Exchange Rate Effect came in at -$27000.0 in Q1 2026, down 28.57% YoY from -$37800.0 in Q1 2025, and up 83.12% on a QoQ basis from -$160000.0 in Q4 2025.
Powered by 
Analysis
Aura Biosciences (AURA) Exchange Rate Effect (2025 - 2026) Analysis & Trends
Aura Biosciences (AURA) has 2 years of Exchange Rate Effect data on file, last reported at -$27000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 28.57% year-over-year to -$27000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$192000.0 (down 814.29% YoY) and the FY2025 annual result came in at -$186000.0, changed N/A from the prior year.
- Exchange Rate Effect grew to -$27000.0 in Q1 2026, from -$160000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $9000.0 in Q2 2025 to a low of -$160000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Aura Biosciences | 717.17 Mn | 649.33 Mn | - | -173,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -173,000.00 |
| Mar 31, 2026 | -27,000.00 |
| Dec 31, 2025 | -160,000.00 |
| Sep 30, 2025 | -14,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | -21,000.00 |